5 active warrant series; nearest expiry 2026-10-14.
Compare this book against every issuer →5 option grants covering 10,920,000 shares (~5.7% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.25 | Oct 14, 2026 17d | 70K | OTM | 0.0% | C$18K | Auto |
| option | $0.05 | Sep 24, 2029 1093d | 4.5M | OTM | 2.3% | C$225K | Auto |
| option | $0.06 | Dec 27, 2029 1187d | 3.3M | OTM | 1.7% | C$195K | Auto |
| option | $0.07 | Jan 24, 2030 1215d | 250K | OTM | 0.1% | C$16K | Auto |
| option | $0.06 | Jun 12, 2030 1354d | 2.9M | OTM | 1.5% | C$171K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
192,435,552 shares outstanding, plus 0 from warrants and 10,920,000 from options — a fully diluted 203,355,552 shares, or ~5.7% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
5 active warrant series; nearest expiry 2026-10-14.
Compare this book against every issuer →5 option grants covering 10,920,000 shares (~5.7% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.25 | Oct 14, 2026 17d | 70K | OTM | 0.0% | C$18K | Auto |
| option | $0.05 | Sep 24, 2029 1093d | 4.5M | OTM | 2.3% | C$225K | Auto |
| option | $0.06 | Dec 27, 2029 1187d | 3.3M | OTM | 1.7% | C$195K | Auto |
| option | $0.07 | Jan 24, 2030 1215d | 250K | OTM | 0.1% | C$16K | Auto |
| option | $0.06 | Jun 12, 2030 1354d | 2.9M | OTM | 1.5% | C$171K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
192,435,552 shares outstanding, plus 0 from warrants and 10,920,000 from options — a fully diluted 203,355,552 shares, or ~5.7% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
